Table 3.
Factors associated with priority rankings in MANCOVA analysis: overall effect*.
| Factor | Global survey F-value (df), p-value | Global survey** F-value (df), p-value | NARCOMS survey** F-value (df), p-value |
|---|---|---|---|
| Type of participant | 6.57 (36), <0.0001 | — | — |
| Region | 2.25 (18), 0.002 | 2.60 (18), 0.0003 | |
| Gender | 2.18 (36), <0.0001 | — | — |
| Race | — | 0.80 (36), 0.80 | |
| Age | 17.3 (18), <0.0001 | 19.3 (18), <0.0001 | 12.2 (18), <0.0001 |
| Education | — | 2.50 (18), 0.0004 | |
| Income | — | 2.92 (36), <0.0001 | |
| No. physical comorbidities | — | 1.09 (54), 0.30 | |
| Anxiety | — | 1.06 (18), 0.39 | |
| Depression | — | 2.95 (18), <0.0001 | |
| Physical activity | — | 2.95 (18), <0.0001 | |
| Smoking status | — | 1.33 (18), 0.16 | |
| Alcohol intake | — | 1.46 (36), 0.036 | |
| Disability status | — | 1.43 (36), 0.048 | |
| Disease-modifying therapy use | — | 2.30 (18), 0.0014 |
*MANCOVA provides evidence of overall effect, but not directionality. **Sample restricted to women with MS. Bold indicates statistical significance.